[Federal Register Volume 67, Number 137 (Wednesday, July 17, 2002)]
[Notices]
[Page 46993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-18039]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science and Regulation of Biological Products: From a Rich 
History to a Challenging Future; Public Symposium

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public symposium.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
symposium entitled ``Science and Regulation of Biological Products: 
From a Rich History to a Challenging Future.'' The purpose of the 
symposium is to commemorate the 100th anniversary of the enactment of 
the Biologics Control Act, the first Federal law regulating biological 
products. The symposium is dedicated to the memory and achievements of 
Dr. Harry Meyer, Jr., who, together with Dr. Paul Parkman, developed 
the first licensed rubella virus vaccine. The Center for Biologics 
Evaluation and Research (CBER) staff and invited guests will present 
scientific lectures describing the achievements of the past and the 
challenges of the future in the areas regulated by CBER (blood, 
vaccines, and therapeutic biological products).
    Date and Time: The public symposium will be held on Monday, 
September 23, 2002, from 8:30 a.m. to 5 p.m., and Tuesday, September 
24, 2002, from 8:30 a.m. to 12 noon.
    Location: The public symposium will be held at the National 
Institutes of Health (NIH), Natcher Conference Center, Bldg. 45, 45 
Center Dr., Bethesda, MD.
    Contact:
    For information about this notice: Michael D. Anderson, Center for 
Biologics Evaluation and Research (HFM-17), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-6210, 
FAX 301-594-1944.
    For information about the public symposium: Gail Sherman, Center 
for Biologics Evaluation and Research (HFM-42), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-2000, 
FAX 301-827-3079, e-mail: [email protected].
    Registration: Mail, fax, or e-mail your registration information 
(including name, professional degree, title, e-mail address, firm name, 
address, telephone, and fax number) to Gail Sherman by September 1, 
2002. There is no registration fee for the public symposium. Space is 
limited, therefore, interested parties are encouraged to register 
early. There will be no onsite registration.
    Travel Information: The NIH campus is accessible via the 
Washington, DC metro system, Red Line, at the Medical Center stop. The 
Natcher Conference Center is a short walk from the metro station, or 
you may take one of the many shuttle buses that run from the metro 
station to the various buildings on the campus. Due to newly imposed 
security measures, visitors parking is limited and use of private 
vehicles may cause significant delays in entering the campus.
    If you need special accommodations due to a disability, please 
contact Gail Sherman at least 7 days in advance.

    Dated: July 11, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-18039 Filed 7-16-02; 8:45 am]
BILLING CODE 4160-01-S